PAINEWEBBER R&D PARTNERS III L P
10-Q, EX-27, 2000-11-14
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: PAINEWEBBER R&D PARTNERS III L P, 10-Q, 2000-11-14
Next: CATELLUS DEVELOPMENT CORP, 10-Q, 2000-11-14



<TABLE> <S> <C>


<ARTICLE>                     5
<CIK>                         0000865936
<NAME>                        PAINEWEBBER R&D PARTNERS III, L.P.

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                              DEC-31-2000
<PERIOD-END>                                   SEP-30-2000
<CASH>                                                   0
<SECURITIES>                                     8,933,809
<RECEIVABLES>                                       19,399
<ALLOWANCES>                                             0
<INVENTORY>                                              0
<CURRENT-ASSETS>                                 8,953,208
<PP&E>                                                   0
<DEPRECIATION>                                           0
<TOTAL-ASSETS>                                   8,953,208
<CURRENT-LIABILITIES>                               51,216
<BONDS>                                                  0
                                    0
                                              0
<COMMON>                                                 0
<OTHER-SE>                                       8,901,992
<TOTAL-LIABILITY-AND-EQUITY>                     8,953,208
<SALES>                                                  0
<TOTAL-REVENUES>                                13,912,017
<CGS>                                                    0
<TOTAL-COSTS>                                            0
<OTHER-EXPENSES>                                   123,482
<LOSS-PROVISION>                                         0
<INTEREST-EXPENSE>                                       0
<INCOME-PRETAX>                                 13,788,535
<INCOME-TAX>                                             0
<INCOME-CONTINUING>                                      0
<DISCONTINUED>                                           0
<EXTRAORDINARY>                                          0
<CHANGES>                                                0
<NET-INCOME>                                    13,788,535
<EPS-BASIC>                                              0
<EPS-DILUTED>                                            0



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission